News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Whiting Samuel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 69,700 options to buy
@ $1.23, valued at
$85.7k
|
|
| 06/22/2022 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 55,680 options to buy
@ $2.35, valued at
$130.8k
|
|
| 01/10/2022 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Bought 1,700 shares
@ $4.8048, valued at
$8.2k
|
|
| 01/06/2022 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $5.45, valued at
$158.1k
|
|
| 06/30/2021 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 201 shares
@ $0
Granted 61,945 options to buy
@ $5.9, valued at
$365.5k
Granted 3,018 options to buy
@ $10.25, valued at
$30.9k
Granted 540,231 options to buy
@ $26.4, valued at
$14.3M
|
|
| 06/30/2021 |
3
| Whiting Samuel (Chief Medical Officer) has filed a Form 3 on Millendo Therapeutics, Inc. |
|
|